LDC’s Grant Goodwin recognised in HealthInvestor Power List 2026

LDC Investment Director Grant Goodwin has been named a finalist in the HealthInvestor Power List 2026.

The annual list, compiled by leading trade publication HealthInvestor, honours the most effective, inspiring and influential leaders in the health and social care sectors.

Grant has been named a finalist in the Equity Investor category, which recognises those who have made significant, successful investments in impactful businesses, effective investment strategies and maximised returns.

Over the last 12 months, Grant played a key role in LDC’s investment in myHappymind in December 2025 and helped Panthera Biopartners acquire Hungary-based OEC in April 2026. He was also involved in LDC’s exit of PAM Healthcare to Optima Health PLC for £100m in March 2026.

Grant has also continued to support LDC’s current healthcare portfolio spanning 14 businesses, working closely with management teams as they pursue their growth ambitions.

LDC has decades of experience supporting management teams in healthcare services, pharma services, and MedTech & devices. Over the last decade, LDC has invested £448m in 19 fast-growing healthcare businesses, with a combined enterprise value of £902m on entry.

The winners of each category, including Equity Investor, will be announced at the HealthInvestor Power List Awards at the London Marriott on 3 December 2026.

LDC extends its congratulations to all those named as finalists in this year’s HealthInvestor Power List. You can see the full list here.